ZA922006B - A composition comprising a peptide for nasal administration - Google Patents

A composition comprising a peptide for nasal administration

Info

Publication number
ZA922006B
ZA922006B ZA922006A ZA922006A ZA922006B ZA 922006 B ZA922006 B ZA 922006B ZA 922006 A ZA922006 A ZA 922006A ZA 922006 A ZA922006 A ZA 922006A ZA 922006 B ZA922006 B ZA 922006B
Authority
ZA
South Africa
Prior art keywords
peptide
composition
nasal administration
nasal
administration
Prior art date
Application number
ZA922006A
Inventor
Annie Rassing Hoelgaard
Rassing Hoelgaard Annie
Birgitte Smedemark Dath
Smedemark Dath Birgitte
Linda Mindeholm
Mindeholm Linda
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of ZA922006B publication Critical patent/ZA922006B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
ZA922006A 1991-03-20 1992-03-19 A composition comprising a peptide for nasal administration ZA922006B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK91497A DK49791D0 (en) 1991-03-20 1991-03-20 NASAL POWDER PREPARATION

Publications (1)

Publication Number Publication Date
ZA922006B true ZA922006B (en) 1992-11-25

Family

ID=8094234

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922006A ZA922006B (en) 1991-03-20 1992-03-19 A composition comprising a peptide for nasal administration

Country Status (5)

Country Link
AU (1) AU1468792A (en)
DK (1) DK49791D0 (en)
MX (1) MX9203615A (en)
WO (1) WO1992016196A1 (en)
ZA (1) ZA922006B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1006873A6 (en) * 1993-03-26 1995-01-10 Merkus Franciscus W H M Administration for drafting nasal insulin delivery.
JP3098401B2 (en) * 1995-07-12 2000-10-16 株式会社エルティーティー研究所 Formulation for nasal administration
JP2006500387A (en) * 2002-08-15 2006-01-05 雲清 劉 Solid nanomedicine and preparation method thereof
CA2528465A1 (en) * 2003-06-09 2005-01-20 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery of growth hormone
JP5254618B2 (en) * 2004-10-11 2013-08-07 ナサリーズ・ピーピーエム・リミテッド Composition for nasal administration
US8202550B2 (en) 2004-10-11 2012-06-19 Nasaleze Ppm Limited Compositions for intranasal administration
GB0422582D0 (en) * 2004-10-11 2004-11-10 Nasaleze Patents Ltd Pharmaceutical compositions
US20090325860A1 (en) * 2006-08-04 2009-12-31 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
HUE049413T2 (en) * 2015-02-17 2020-09-28 Lilly Co Eli Nasal powder formulation for treatment of hypoglycemia
TWI771669B (en) * 2019-04-26 2022-07-21 美商美國禮來大藥廠 Method for preparing stable peptide formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (en) * 1983-03-09 1984-09-14 Teijin Ltd Peptide hormone composition for nasal administration
IL78425A (en) * 1985-04-15 1991-05-12 Lilly Co Eli Intranasal formulation containing insulin
GB8712176D0 (en) * 1987-05-22 1987-06-24 Cosmas Damian Ltd Drug delivery system
NL9001681A (en) * 1990-07-24 1992-02-17 Rijksuniversiteit TRANSMUCOSAL MEDICINAL PRODUCT PREPARATIONS AND TRANSMUCOSAL ADMINISTRATION.

Also Published As

Publication number Publication date
MX9203615A (en) 1992-09-01
WO1992016196A1 (en) 1992-10-01
AU1468792A (en) 1992-10-21
DK49791D0 (en) 1991-03-20

Similar Documents

Publication Publication Date Title
IL104068A0 (en) Pharmaceutical compositions for inhalation
GB9120024D0 (en) Nasal pharmaceutical composition
IL101289A0 (en) Inhaler for solid medicaments
ZA937697B (en) Pharmaceutical compositions containing a calcitonin
HU9401474D0 (en) New peptide derivatives
GB9108080D0 (en) Pharmaceutical composition
AP9200356A0 (en) Pharmaceutical composition
ZA922006B (en) A composition comprising a peptide for nasal administration
IL102372A0 (en) Pharmaceutical composition containing a non-n-methyl-d-aspartate antagonist
GB2257908B (en) Calcitonin analogue for transmucosal administration
IL97365A0 (en) Pharmaceutical compositions comprising a lymphokine
GB2252497B (en) Pharmaceutical composition
GB9206151D0 (en) Nasal pharmaceutical composition
GB9018039D0 (en) A pharmaceutical composition
ZA916592B (en) A pharmaceutical composition
ZA921541B (en) Peptide analogues
GB9111477D0 (en) Pharmaceutical composition
ZA923243B (en) New peptide compound and a process for the preparation thereof
HU911556D0 (en) A new medicament
GB9121304D0 (en) A novel pharmaceutical formulation
GB9320906D0 (en) Medicament administration inhaler
IL100147A0 (en) Pharmaceutical delivery system
GB9119399D0 (en) Oral delivery system
IL97079A0 (en) Nasal drops
GB9101527D0 (en) Inhaler